Holen Sie sich die Stockscreener-App
21.77
3.43%
0.765
Schlusskurs vom Vortag:
$21.01
Offen:
$21.14
24-Stunden-Volumen:
98,015
Relative Volume:
0.34
Marktkapitalisierung:
$666.05M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-3.9735
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
+5.13%
1M Leistung:
+12.77%
6M Leistung:
+28.88%
1J Leistung:
-9.50%
1-Tages-Spanne:
$21.09
$21.93
1-Wochen-Bereich:
$19.59
$21.93
52-Wochen-Spanne:
$14.76
$24.00
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Vergleichen Sie FLGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
21.76 | 630.85M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
485.65 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
208.91 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
662.67 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.93 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.36 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Is Fulgent Genetics Inc. in Accumulation Phase Now2025 Earnings Surprises & AI Forecasted Entry/Exit Points - 선데이타임즈
XTX Topco Ltd Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Inc. Recovery Likely Here’s What Data ShowsROI Boosting Trade Opportunity Calendar Published - beatles.ru
What earnings revisions data tells us about Fulgent Genetics Inc.Community Picked Stocks with Trade Insights - Newser
What moving averages say about Fulgent Genetics Inc.ROI Focused Setup With Drawdown Analysis - Newser
Using economic indicators to assess Fulgent Genetics Inc. potentialStrong Buy Signal Summary with Entry Zone - Newser
Fulgent Genetics (NASDAQ:FLGT) Trading Up 9.3%Should You Buy? - MarketBeat
Published on: 2025-08-10 02:50:30 - Newser
Fulgent Genetics (NASDAQ:FLGT) Upgraded to "Buy" at UBS Group - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) PT Set at $21.00 by Piper Sandler - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Trading Down 3.4% Following Analyst Downgrade - MarketBeat
Fulgent Reports Second Quarter 2025 Financial Results - The Globe and Mail
Fulgent Genetics Inc. Stock Performance After Earnings: Historical InsightsFree Daily Volume Spike Trading Signals - Newser
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price In Tune With Revenues - 富途牛牛
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Is On The Mark - simplywall.st
Fulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings Guidance - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Issues Earnings Results - MarketBeat
UBS Upgrades Fulgent Genetics to Buy From Neutral, Adjusts Price Target to $30 From $20 - MarketScreener
Fulgent Genetics stock rating upgraded to Buy at UBS on growth potential - Investing.com Canada
Detecting price anomalies in Fulgent Genetics Inc. with AIEntry Zone Forecast for Momentum Trading - Newser
Fulgent Genetics lifts 2025 revenue outlook to $320M and narrows EPS loss guidance while advancing clinical pipeline - MSN
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Earnings Beat - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Bank of New York Mellon Corp - MarketBeat
Published on: 2025-08-04 03:43:28 - Jammu Links News
When is Fulgent Genetics Inc. stock expected to show significant growthDiscover market opportunities with expert help - Jammu Links News
What analysts say about Fulgent Genetics Inc. stockDiscover hidden gems in the stock market - Jammu Links News
Is Fulgent Genetics Inc. a growth stock or a value stockAchieve remarkable returns with smart investing - Jammu Links News
Fulgent Genetics Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
How does Fulgent Genetics Inc. generate profit in a changing economyTrack emerging stocks with high growth potential - Jammu Links News
What institutional investors are buying Fulgent Genetics Inc. stockUnlock exclusive investment alerts - Jammu Links News
How strong is Fulgent Genetics Inc. company’s balance sheetGet real-time alerts on high-potential stocks - Jammu Links News
Should I hold or sell Fulgent Genetics Inc. stock in 2025Unlock expert stock analysis and alerts - Jammu Links News
What makes Fulgent Genetics Inc. stock price move sharplyExplosive returns - Jammu Links News
Fulgent Genetics Tops Expectations But Still Faces Losses - Finimize
What is the dividend policy of Fulgent Genetics Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript - Insider Monkey
Fulgent (FLGT) Q2 Revenue Jumps 16% - The Globe and Mail
Fulgent Genetics Reports Q2 2025 Financial Results - The Globe and Mail
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... By GuruFocus - Investing.com Canada
GSA Capital Partners LLP Acquires 85,481 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Reports Strong Core Revenue Growth - TipRanks
Fulgent Genetics 2025 Q2 Earnings Revenue Surges 15.2% as Losses Widen - AInvest
What are analysts’ price targets for Fulgent Genetics Inc. in the next 12 monthsChart Pattern Planner With Low Risk - Jammu Links News
Why Fulgent Genetics Stock Was Crushing It on Friday - The Motley Fool
Why Fulgent Genetics Stock Was Crushing It on Friday - The Globe and Mail
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.73%
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):